RNAi for Therapeutic 2017 Global Market Key Players - Alnylam Pharmaceuticals, Arbutus Biopharma (Tekmira), Arrowhead Research, Dicerna Pharmaceuticals, Mirna Therapeutics, Quark Pharmaceuticals, RXi Pharmaceuticals, Silence Therapeutics, Benitec Biopharm

RNAi for Therapeutic Market

Description:

This report studies the global RNAi for Therapeutic market, analyzes and researches the RNAi for Therapeutic development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Alnylam Pharmaceuticals,
Arbutus Biopharma (Tekmira),
Arrowhead Research,
Dicerna Pharmaceuticals,
Mirna Therapeutics,
Quark Pharmaceuticals,
RXi Pharmaceuticals,
Silence Therapeutics,
Benitec Biopharma,
Miragen Therapeutics
Sylentis
Gradalis
Sirnaomics
Silenseed

Request for Sample Report@ https://www.wiseguyreports.com/sample-request/1139146-global-rnai-for-therapeutic-market-size-status-and-forecast-2022

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, RNAi for Therapeutic can be split into
siRNA 3
miRNA 4
shRNA 5

Market segment by Application, RNAi for Therapeutic can be split into
Cancer
Cardiovascular
HBV
Other

Enquiry before Buying @ https://www.wiseguyreports.com/enquiry/1139146-global-rnai-for-therapeutic-market-size-status-and-forecast-2022

Table of Contents:
Global RNAi for Therapeutic Market Size, Status and Forecast 2022
1 Industry Overview of RNAi for Therapeutic
1.1 RNAi for Therapeutic Market Overview
1.1.1 RNAi for Therapeutic Product Scope
1.1.2 Market Status and Outlook
1.2 Global RNAi for Therapeutic Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 RNAi for Therapeutic Market by Type
1.3.1 siRNA 3
1.3.2 miRNA 4
1.3.3 shRNA 5
1.4 RNAi for Therapeutic Market by End Users/Application
1.4.1 Cancer
1.4.2 Cardiovascular
1.4.3 HBV
1.4.4 Other

2 Global RNAi for Therapeutic Competition Analysis by Players
2.1 RNAi for Therapeutic Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Alnylam Pharmaceuticals
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Arbutus Biopharma (Tekmira)
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Arrowhead Research
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Dicerna Pharmaceuticals
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Mirna Therapeutics
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Quark Pharmaceuticals
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 RXi Pharmaceuticals
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Silence Therapeutics
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Benitec Biopharma
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Miragen Therapeutics
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 RNAi for Therapeutic Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Sylentis
3.12 Gradalis
3.13 Sirnaomics
3.14 Silenseed

4 Global RNAi for Therapeutic Market Size by Type and Application (2012-2017)
4.1 Global RNAi for Therapeutic Market Size by Type (2012-2017)
4.2 Global RNAi for Therapeutic Market Size by Application (2012-2017)
4.3 Potential Application of RNAi for Therapeutic in Future
4.4 Top Consumer/End Users of RNAi for Therapeutic

5 United States RNAi for Therapeutic Development Status and Outlook
5.1 United States RNAi for Therapeutic Market Size (2012-2017)
5.2 United States RNAi for Therapeutic Market Size and Market Share by Players (2016 and 2017)

8 China RNAi for Therapeutic Development Status and Outlook
8.1 China RNAi for Therapeutic Market Size (2012-2017)
8.2 China RNAi for Therapeutic Market Size and Market Share by Players (2016 and 2017)
Continued...

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1139146

Contact US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

About Us:
Wise Guy Reports Is Part Of The Wise Guy Consultants Pvt. Ltd. And Offers Premium Progressive Statistical Surveying, Market Research Reports, Analysis & Forecast Data For Industries And Governments Around The Globe. Wise Guy Reports Features An Exhaustive List Of Market Research Reports From Hundreds Of Publishers Worldwide. We Boast A Database Spanning Virtually Every Market Category And An Even More Comprehensive Collection Of Market Research Reports Under These Categories And Sub-Categories.

Addres:
: Wise Guy Research Consultants Pvt Ltd
: Pune – 411028
: Maharashtra, India
: Ph: +91 841 198 5042

This release was published on openPR.